FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Bisacchi

Research Profile

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Manashi Sherawat; Punit Kaur; Markus Perbandt; Christian Betzel; William A Slusarchyk; Gregory S Bisacchi; Chiehying Chang; Bruce L Jacobson; Howard M Einspahr; Tej P Singh
Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
Yan Shi; Jing Zhang; Philip D Stein; Mengxiao Shi; Stephen P O'Connor; Sharon N Bisaha; Chi Li; Karnail S Atwal; Gregory S Bisacchi; Doree Sitkoff; Andrew T Pudzianowski; Eddie C-K Liu; Karen S Hartl; Steven M Seiler; Sonia Youssef; Thomas E Steinbacher; William A Schumacher; Alan R Rendina; Jeffrey M Bozarth; Tara L Peterson; Ge Zhang; Robert Zahler
Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors.
James C Sutton; Scott A Bolton; Malcolm E Davis; Karen S Hartl; Bruce Jacobson; Arvind Mathur; Martin Ogletree; William A Slusarchyk; Robert Zahler; Steven M Seiler; Gregory S Bisacchi
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Bisacchi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Manashi Sherawat; Punit Kaur; Markus Perbandt; Christian Betzel; William A Slusarchyk; Gregory S Bisacchi; Chiehying Chang; Bruce L Jacobson; Howard M Einspahr; Tej P Singh
Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
Acta crystallographica. Section D, Biological crystallography 2007;63(Pt 4):500-7.
2005: Yan Shi; Jing Zhang; Philip D Stein; Mengxiao Shi; Stephen P O'Connor; Sharon N Bisaha; Chi Li; Karnail S Atwal; Gregory S Bisacchi; Doree Sitkoff; Andrew T Pudzianowski; Eddie C-K Liu; Karen S Hartl; Steven M Seiler; Sonia Youssef; Thomas E Steinbacher; William A Schumacher; Alan R Rendina; Jeffrey M Bozarth; Tara L Peterson; Ge Zhang; Robert Zahler
Ketene aminal-based lactam derivatives as a novel class of orally active FXa inhibitors.
Bioorganic & medicinal chemistry letters 2005;15(24):5453-8.
2004: James C Sutton; Scott A Bolton; Malcolm E Davis; Karen S Hartl; Bruce Jacobson; Arvind Mathur; Martin Ogletree; William A Slusarchyk; Robert Zahler; Steven M Seiler; Gregory S Bisacchi
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
Bioorganic & medicinal chemistry letters 2004;14(9):2233-9.
2004: Gregory S Bisacchi; William A Slusarchyk; Scott A Bolton; Karen S Hartl; Glenn Jacobs; Arvind Mathur; Wei Meng; Martin Ogletree; Zulan Pi; James C Sutton; Uwe Treuner; Robert Zahler; Guohua Zhao; Steven M Seiler
Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
Bioorganic & medicinal chemistry letters 2004;14(9):2227-31.
2004: Guohua Zhao; Scott A Bolton; Chet Kwon; Karen S Hartl; Steven M Seiler; William A Slusarchyk; James C Sutton; Gregory S Bisacchi
Synthesis of potent and selective 2-azepanone inhibitors of human tryptase.
Bioorganic & medicinal chemistry letters 2004;14(2):309-12.
2002: William A Slusarchyk; Scott A Bolton; Karen S Hartl; Ming-Hsing Huang; Glenn Jacobs; Wei Meng; Martin Ogletree; Zulan Pi; William A Schumacher; Steven M Seiler; James C Sutton; Uwe Treuner; Robert Zahler; Guohua Zhao; Gregory S Bisacchi
Synthesis of potent and highly selective inhibitors of human tryptase.
Bioorganic & medicinal chemistry letters 2002;12(21):3235-8.
2002: James C Sutton; Scott A Bolton; Karen S Hartl; Ming-Hsing Huang; Glenn Jacobs; Wei Meng; Martin Ogletree; Zulan Pi; William A Schumacher; Steven M Seiler; William A Slusarchyk; Uwe Treuner; Robert Zahler; Guohua Zhao; Gregory S Bisacchi
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
Bioorganic & medicinal chemistry letters 2002;12(21):3229-33.
1999: Gregory Yamanaka; T Wilson; SF Innaimo; Gregory S Bisacchi; P Egli; J K Rinehart; Robert Zahler; Richard J Colonno
Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.
Antimicrobial agents and chemotherapy 1999;43(1):190-3.
1998: Keith Combrink; H B Gülgeze; Nicholas A Meanwell; Bradley C Pearce; P Zulan; Gregory S Bisacchi; Daniel G M Roberts; P Stanley; Steven M Seiler
1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Journal of medicinal chemistry 1998;41(24):4854-60.
1997: SF Innaimo; M Seifer; Gregory S Bisacchi; David Standring; Robert Zahler; Richard J Colonno
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.
Antimicrobial agents and chemotherapy 1997;41(7):1444-8.
1996: P Chen; P T Cheng; M Alam; B D Beyer; Gregory S Bisacchi; T Dejneka; A J Evans; J A Greytok; Mark Hermsmeier; W G Humphreys; G A Jacobs; O Kocy; Pin-Fang Lin; K A Lis; M A Marella; Denis E Ryono; AK Sheaffer; S H Spergel; C Q Sun; J A Tino; G Vite; Richard J Colonno; Robert Zahler; J C Barrish
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.
Journal of medicinal chemistry 1996;39(10):1991-2007.
1994: J C Barrish; E Gordon; M Alam; Pin-Fang Lin; Gregory S Bisacchi; P Chen; P T Cheng; A W Fritz; J A Greytok; Mark Hermsmeier
Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.
Journal of medicinal chemistry 1994;37(12):1758-68.
1992: William A Slusarchyk; Gregory S Bisacchi; A K Field; D R Hockstein; G A Jacobs; B McGeever-Rubin; J A Tino; A V Tuomari; Gregory Yamanaka; M G Young
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.
Journal of medicinal chemistry 1992;35(10):1799-806.
1991: Gregory Yamanaka; A V Tuomari; M Hagen; B McGeever-Rubin; B Terry; M Haffey; Gregory S Bisacchi; A K Field
Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
Molecular pharmacology 1991;40(3):446-53.
1991: Gregory S Bisacchi; A Braitman; Christopher Cianci; J M Clark; A K Field; M E Hagen; D R Hockstein; M F Malley; T Mitt; William A Slusarchyk
Synthesis and antiviral activity of enantiomeric forms of cyclobutyl nucleoside analogues.
Journal of medicinal chemistry 1991;34(4):1415-21.
1987: Gregory S Bisacchi; D R Hockstein; W H Koster; W L Parker; M L Rathnum; S E Unger
Xylocandin: a new complex of antifungal peptides. II. Structural studies and chemical modifications.
The Journal of antibiotics 1987;40(11):1520-9.
1987: E Meyers; Gregory S Bisacchi; L Dean; W C Liu; Beatrice Minassian; D S Slusarchyk; R B Sykes; S K Tanaka; W Trejo
Xylocandin: a new complex of antifungal peptides. I. Taxonomy, isolation and biological activity.
The Journal of antibiotics 1987;40(11):1515-9.